Search results
Leerink Partnrs Weighs in on Intra-Cellular Therapies, Inc.’s FY2025 Earnings (NASDAQ:ITCI)
ETF DAILY NEWS· 1 day ago(NASDAQ:ITCI – Free Report) – Analysts at Leerink Partnrs raised their FY2025 earnings estimates for Intra-Cellular Therapies in a note issued to investors on Tuesday, May ...
Apollomics (NASDAQ:APLM) PT Lowered to $2.00 at HC Wainwright
ETF DAILY NEWS· 1 day agoApollomics (NASDAQ:APLM – Free Report) had its price objective trimmed by HC Wainwright from $5.00 to $2.00 in a research note issued to investors on Wednesday morning, Benzinga ...
The Inventor of the Chatbot Tried to Warn Us About A.I.
The New Republic via Yahoo News· 4 days agoThe book is dotted with equations and scraps of code, almost as if he were working out some thoughts...
Precigen (PGEN) to Release Quarterly Earnings on Tuesday
ETF DAILY NEWS· 10 hours agoPrecigen (NASDAQ:PGEN – Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, May 14th. Analysts expect Precigen to post earnings of ($0.09) per share ...
Coya Therapeutics (NASDAQ:COYA) Stock Rating Reaffirmed by Chardan Capital
ETF DAILY NEWS· 1 day agoCoya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by Chardan Capital in a note issued to investors on Thursday, Benzinga reports. They ...
Earnings call: ClearPoint Neuro sees robust Q1 growth with diverse revenue streams By Investing.com
Investing.com· 3 days agoThis growth was driven by significant gains in biologics and drug delivery, as well as capital...
Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 1 day agoNeedham & Company LLC reissued their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports ...
ClearPoint Neuro Inc (CLPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth ...
GuruFocus.com via Yahoo Finance· 4 days agoFunctional Neurosurgery, Navigation, and Therapy Revenue: Declined 18% to $1.9 million in Q1 2024. Capital Equipment and Software Revenue: Increased 255% ...
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Target Price at $15.40
ETF DAILY NEWS· 1 day agoChardan Capital reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Tenaya Therapeutics in a research note on Thursday, March 21st. Finally, HC Wainwright ...
Leerink Partnrs Comments on Trevi Therapeutics, Inc.’s FY2024 Earnings (NASDAQ:TRVI)
ETF DAILY NEWS· 1 day agoTrevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) – Stock analysts at Leerink Partnrs cut their FY2024 EPS estimates for Trevi Therapeutics in a research note issued to ...
